STRIVE, INC. (ASST) FY2026 Q2 P&L / Income Statement

STRIVE, INC. (ASST) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

2,941,000 US dollars

Operating costs, including other operating expenses (calculated)

261,190,000 US dollars

Net operating loss

negative 258,249,000 US dollars

Total other income/(expense)

646,000 US dollars

Net loss before income taxes

negative 257,603,000 US dollars

Income tax benefit/(expense)

0 US dollars

Net loss

negative 257,603,000 US dollars

Asset Management - Medical device revenues

0 US dollars

Asset Management - Investment advisory fees

1,512,000 US dollars

Asset Management - Other revenue

0 US dollars

Medical Device - Medical device revenues

1,388,000 US dollars

Medical Device - Investment advisory fees

0 US dollars

Medical Device - Other revenue

0 US dollars

Corporate & Other - Medical device revenues

0 US dollars

Corporate & Other - Investment advisory fees

0 US dollars

Corporate & Other - Other revenue

41,000 US dollars

Total operating expenses

24,396,000 US dollars

Total investment losses

236,794,000 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.